This is true, although I would prefer to still test everyone for plausibly important things to feed data analysts who might eventually discover something useful.
I'd love for that to be true, but there's a good chance that in doing broad tests you are incurring costs (both to patient health and cost [whether paid by patient, gov, or insurance company]) without getting anything beyond noisy data without useful signal